Point72 Asset Management, L.P. 13D and 13G filings for Bright Minds Biosciences Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | Bright Minds Biosciences Inc. DRUG |
Point72 Asset Management, L.P. | 135,189 3.000% |
-299,811 (-68.92%) |
Filing |
| 2024-10-23 6:01 pm Purchase |
2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG |
Point72 Asset Management, L.P. | 435,000 9.700% |
435,000 (New Position) |
Filing |